Lead
PFAS: per- and polyfluoroalkyl substances — a large family of synthetic chemicals used for water and stain resistance that persist in the environment and the body — per- and polyfluoroalkyl substances — has begun appearing in parenting contexts. Water-repellent baby outerwear, nonstick cookware, waterproofed rain gear: these are among the products that have relied on this family of compounds. In April 2024, the US Environmental Protection Agency set the first federal drinking-water standards for PFAS in American history [1]. Regulatory tightening is proceeding in the EU as well. Japan's Food Safety Commission has ongoing PFOS and PFOA evaluations underway.
The reasonable response to this is not alarm, but orientation. What does the science actually establish about PFAS and health, what is still uncertain, and what, if anything, changes in daily life as a result? This article focuses on those questions.
What PFAS are — and why their diversity matters
PFAS is a collective term covering anywhere from 4,000 to over 12,000 individual compounds. What they share is an exceptionally stable carbon-fluorine bond — the structural reason why PFAS resist degradation in the environment and in the body, earning the description forever chemicals: nickname for substances that essentially do not break down naturally, accumulating in soil, water, and bodies over decades.
The compounds with the most extensive research record are PFOS (perfluorooctane sulfonic acid) and PFOA (perfluorooctanoic acid). The major manufacturers voluntarily phased out production of both compounds in the early 2000s, and EU regulations under the REACH framework impose strict restrictions. But because PFOS and PFOA are so persistent, both continue to be detected in environmental samples and in human blood.
One structural parallel is worth noting here: shorter-chain PFAS were introduced as replacements for PFOS and PFOA when those compounds came under regulatory pressure. Whether these substitutes carry similar health concerns is an active area of research. The pattern is structurally similar to the BPA-to-BPS substitution discussed in article 110: regulatory pressure on one compound leads to a structurally related replacement whose long-term profile is less well characterized.
How infants and toddlers are exposed
The human exposure pathways for PFAS are multiple. A comprehensive review by Sunderland and colleagues identifies food, drinking water, and the indoor environment (settled dust, air) as the major routes [2]. Food — particularly fish, seafood, and animal products — may account for over 40% of PFOA and PFOS exposure in adults [2]. PFAS accumulate through food chains because they are persistent.
For infants specifically, breast milk is an important exposure pathway. A birth cohort study: long-term research that follows a group of children from birth onward to track health outcomes over time from the Faroe Islands by Mogensen and colleagues tracked serum PFAS concentrations in children at birth, 11 months, 18 months, and 60 months, demonstrating that serum PFAS levels rose during the period of active breastfeeding and declined after weaning [3]. This confirms that breast milk contributes to infant PFAS exposure.
A word on proportion is needed here. The scientific and public health consensus — reflected in WHO guidance and in the position of ATSDR and other agencies [5] — is that the well-documented benefits of breastfeeding substantially outweigh the risks associated with PFAS transfer through breast milk. This is not a close call in the literature. For parents who are breastfeeding and encounter this data, the appropriate reading is context-setting about one of several exposure pathways, not a reason to reconsider breastfeeding.
Water-repellent and stain-resistant textile products can be a PFAS source; so can PFAS-containing food packaging. The contribution of nonstick cookware to dietary PFAS exposure through normal use is considered limited compared to food and drinking water, though cookware with significantly damaged coating should not continue to be used.
Regulatory benchmarks and what they reflect
In 2020, EFSA's CONTAM Panel established a group Tolerable Weekly Intake (TWI) for four PFAS (PFOS, PFOA, PFNA, and PFHxS) of 4.4 nanograms per kilogram of body weight per week [4]. The critical health endpoint that drove this benchmark was a measurable reduction in vaccine antibody response following immunization — a finding that was identified in several independent cohort studies. EFSA noted that estimated exposure in portions of the European population likely exceeds this TWI [4].
In April 2024, the EPA set the Maximum Contaminant Level (MCL) for PFOA and PFOS in drinking water at 4 parts per trillion (nanograms per liter) — an exceptionally low threshold [1]. EPA projections estimated this regulation would prevent thousands of deaths and tens of thousands of serious illnesses if fully implemented. For context, 4 ppt is at the boundary of what current detection methods can reliably measure.
Two related points help frame what strict regulatory thresholds actually mean. First, very tight standards for PFAS reflect the compounds' high persistence and bioaccumulation: the buildup of chemicals in living organisms over time, often reaching higher levels than in the surrounding environment properties: small chronic exposures accumulate over time rather than being rapidly cleared. Strict regulations for PFAS are not evidence that PFAS are acutely toxic at common exposure levels in the way that, say, acute chemical poisonings operate. Second, the PFAS family spans thousands of compounds with differing properties. Generalizing from the best-studied agents (PFOS, PFOA) to "PFAS as a whole are dangerous" overstates what the evidence supports. The science is uneven across the family.
What the health effects evidence shows
For PFOS and PFOA, the areas where epidemiological evidence is comparatively consistent include: immune function (particularly vaccine antibody response, as EFSA noted [4]); cholesterol levels; thyroid function; and associations with certain cancers, including kidney and testicular cancer [2,4]. Most of these findings come from studies in adults or older children; high-quality longitudinal data linking early infant PFAS exposure to adult health outcomes remains limited.
The ATSDR toxicological profile for PFAS and the Fenton and colleagues review provide the most comprehensive current synthesis [5,7]. Both documents note that effect sizes vary considerably across studies, that confounding is difficult to control, and that more research is needed before firm dose-response relationships can be established for many endpoints.
Practical orientation
What can a family reasonably do with this information?
- The most direct way to assess PFAS in drinking water is to look up your municipal water quality report. Most water utilities in Japan and other developed countries publish routine monitoring data. Residents in areas known to have elevated PFAS groundwater contamination have the most reason to investigate filtration options.
- Replace nonstick cookware that has visibly damaged coating; this is a reasonable step regardless of specific PFAS concerns, since any degraded coating may introduce particles into food.
- For water-repellent infant products (rain gear, mattress covers), the exposure contribution through normal use is generally lower than through food and water, but for items that infants mouth frequently, checking material information is a proportionate step.
- Breastfeeding: as discussed, the balance of evidence strongly favors continuing breastfeeding. The Faroe Islands cohort [3] documents exposure, but the health benefits of breast milk for infant immune development, gut health, and long-term outcomes are supported by a substantially larger evidence base than the PFAS-via-breast-milk risk pathway.
Summary
PFAS is a family of thousands of compounds with an uneven evidence record. The most researched members — PFOS and PFOA — have been associated in epidemiological studies with effects on immune function (particularly vaccine response), cholesterol, thyroid function, and certain cancers. Both EFSA and the US EPA have set strict regulatory thresholds, reflecting the compounds' persistence and bioaccumulation properties rather than acute high toxicity. Infants' exposure pathways include food, drinking water, and breast milk; the scientific consensus is that breastfeeding benefits substantially outweigh PFAS transfer risks. The evidence base for long-term health outcomes specifically in infants and toddlers remains limited. Living with this uncertainty means knowing the exposure pathways, checking drinking-water quality data when relevant, and making proportionate product choices rather than attempting total avoidance of a compound family present throughout the environment.
References
- US Environmental Protection Agency. PFAS National Primary Drinking Water Regulation. Federal Register. 2024;89(80):32532–32757. https://www.epa.gov/sdwa/and-polyfluoroalkyl-substances-pfas
- Sunderland EM, Hu XC, Dassuncao C, Tokranov AK, Wagner CC, Allen JG. A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects. J Expo Sci Environ Epidemiol. 2019;29(2):131–147. doi:10.1038/s41370-018-0094-1. PMID: 30470793.
- Mogensen UB, Grandjean P, Nielsen F, Weihe P, Budtz-Jørgensen E. Breastfeeding as an exposure pathway for perfluorinated alkylates. Environ Sci Technol. 2015;49(17):10466–10473. doi:10.1021/acs.est.5b02237. PMID: 26291735.
- European Food Safety Authority CONTAM Panel. Risk to human health related to the presence of perfluoroalkyl substances in food. EFSA Journal. 2020;18(9):e06223. doi:10.2903/j.efsa.2020.6223.
- Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Perfluoroalkyls. US Department of Health and Human Services; 2021. https://www.atsdr.cdc.gov/toxprofiles/tp200.pdf
- Grandjean P, Timmermann CAG, Kruse M, et al. Severity of COVID-19 at elevated exposure to perfluorinated alkylates. PLoS One. 2020;15(12):e0244815. doi:10.1371/journal.pone.0244815. PMID: 33140071. [unverified: Japanese draft listed PMID 33382768; PubMed search returned PMID 33140071 for this paper — corrected]
- Fenton SE, Ducatman A, Boobis A, et al. Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research. Environ Toxicol Chem. 2021;40(3):606–630. doi:10.1002/etc.4890. PMID: 33017053.